Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands

NCT06685978 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
430
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tasly Pharmaceutical Group Co., Ltd